Beese Fulmer Investment Management, Inc. Abb Vie Inc. Transaction History

Beese Fulmer Investment Management, Inc.

  • $1.14 Billion
  • Q3 2024

A detailed history of Beese Fulmer Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 35,318 shares of ABBV stock, worth $6.19 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
35,318
Previous 35,626 0.86%
Holding current value
$6.19 Million
Previous $6.11 Million 14.14%
% of portfolio
0.61%
Previous 0.57%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$163.84 - $199.33 $50,462 - $61,393
-308 Reduced 0.86%
35,318 $6.97 Million
Q2 2024

Jul 03, 2024
SELL
$154.79 - $180.76 $93,183 - $108,817
-602 Reduced 1.66%
35,626 $6.11 Million
Q1 2024

Apr 08, 2024
SELL
$159.82 - $182.1 $154,386 - $175,908
-966 Reduced 2.6%
36,228 $6.6 Million
Q4 2023

Jan 09, 2024
SELL
$137.6 - $154.97 $7,980 - $8,988
-58 Reduced 0.16%
37,194 $5.76 Million
Q3 2023

Oct 10, 2023
SELL
$133.59 - $154.65 $86,833 - $100,522
-650 Reduced 1.71%
37,252 $5.55 Million
Q2 2023

Jul 11, 2023
SELL
$132.51 - $164.9 $121,511 - $151,213
-917 Reduced 2.36%
37,902 $5.11 Million
Q1 2023

Apr 11, 2023
SELL
$144.61 - $166.54 $78,667 - $90,597
-544 Reduced 1.38%
38,819 $6.19 Million
Q4 2022

Jan 17, 2023
SELL
$138.31 - $165.87 $71,644 - $85,920
-518 Reduced 1.3%
39,363 $0
Q3 2022

Oct 06, 2022
SELL
$134.21 - $153.93 $46,168 - $52,951
-344 Reduced 0.86%
39,881 $5.35 Million
Q2 2022

Jul 11, 2022
SELL
$137.62 - $174.96 $71,287 - $90,629
-518 Reduced 1.27%
40,225 $6.16 Million
Q1 2022

Apr 12, 2022
SELL
$131.98 - $163.75 $141,878 - $176,031
-1,075 Reduced 2.57%
40,743 $6.61 Million
Q4 2021

Jan 10, 2022
SELL
$107.43 - $135.93 $25,675 - $32,487
-239 Reduced 0.57%
41,818 $5.66 Million
Q3 2021

Oct 08, 2021
SELL
$106.4 - $120.78 $19,684 - $22,344
-185 Reduced 0.44%
42,057 $4.54 Million
Q2 2021

Jul 08, 2021
BUY
$105.21 - $117.21 $19,674 - $21,918
187 Added 0.44%
42,242 $4.76 Million
Q1 2021

Apr 23, 2021
BUY
$102.3 - $112.62 $209,715 - $230,871
2,050 Added 5.12%
42,055 $4.55 Million
Q4 2020

Jan 20, 2021
SELL
$80.49 - $108.67 $105,039 - $141,814
-1,305 Reduced 3.16%
40,005 $4.29 Million
Q3 2020

Oct 08, 2020
SELL
$85.91 - $100.83 $13,745 - $16,132
-160 Reduced 0.39%
41,310 $3.62 Million
Q2 2020

Jul 17, 2020
SELL
$73.37 - $98.18 $219,156 - $293,263
-2,987 Reduced 6.72%
41,470 $4.07 Million
Q1 2020

Apr 09, 2020
SELL
$64.5 - $97.79 $6,450 - $9,779
-100 Reduced 0.22%
44,457 $3.39 Million
Q4 2019

Feb 05, 2020
BUY
$72.13 - $90.25 $126,660 - $158,479
1,756 Added 4.1%
44,557 $3.95 Million
Q3 2019

Nov 01, 2019
BUY
$62.98 - $75.72 $1.97 Million - $2.37 Million
31,336 Added 273.32%
42,801 $3.24 Million
Q2 2019

Jul 05, 2019
SELL
$65.7 - $83.98 $77,000 - $98,424
-1,172 Reduced 9.27%
11,465 $834,000
Q1 2019

Apr 05, 2019
SELL
$77.14 - $90.79 $11,416 - $13,436
-148 Reduced 1.16%
12,637 $1.02 Million
Q4 2018

Jan 25, 2019
SELL
$77.85 - $96.01 $35,811 - $44,164
-460 Reduced 3.47%
12,785 $1.18 Million
Q3 2018

Oct 09, 2018
SELL
$88.91 - $98.84 $17,782 - $19,768
-200 Reduced 1.49%
13,245 $1.25 Million
Q2 2018

Jul 20, 2018
SELL
$89.78 - $106.23 $35,103 - $41,535
-391 Reduced 2.83%
13,445 $1.25 Million
Q1 2018

Apr 16, 2018
SELL
$92.01 - $123.21 $16,653 - $22,301
-181 Reduced 1.29%
13,836 $1.31 Million
Q4 2017

Jan 26, 2018
SELL
$89.56 - $98.21 $6,717 - $7,365
-75 Reduced 0.53%
14,017 $1.36 Million
Q3 2017

Oct 17, 2017
BUY
$69.85 - $89.22 $984,326 - $1.26 Million
14,092
14,092 $1.25 Million

Others Institutions Holding ABBV

# of Institutions
3,855
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Beese Fulmer Investment Management, Inc. Portfolio

Follow Beese Fulmer Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email